The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $65.94

Today's change-0.13 -0.20%
Updated April 28 4:01 PM EDT. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $65.94

Today's change-0.13 -0.20%
Updated April 28 4:01 PM EDT. Delayed by at least 15 minutes.

AbbVie Inc down (U.S.)$0.13

AbbVie Inc closed lower Friday, dropping (U.S.)$0.13 or 0.20% to (U.S.)$65.94. Over the last five days, shares have gained 3.32% and are currently 3.21% off of the 52-week high. Shares have underperformed the S&P 500 by 7.11% during the last year.

Key company metrics

  • Open(U.S.) $66.06
  • Previous close(U.S.) $66.07
  • High(U.S.) $66.32
  • Low(U.S.) $65.44
  • Bid / Ask-- / --
  • YTD % change+5.30%
  • Volume5,521,146
  • Average volume (10-day)5,587,234
  • Average volume (1-month)5,326,439
  • Average volume (3-month)6,483,468
  • 52-week range(U.S.) $55.06 to (U.S.) $68.12
  • Beta1.54
  • Trailing P/E16.98×
  • P/E 1 year forward11.97×
  • Forward PEG0.84×
  • Indicated annual dividend(U.S.) $2.56
  • Dividend yield3.88%
  • Trailing EPS(U.S.) $3.88
Updated April 28 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.51%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue6,7966,4326,4525,958
Total other revenue--------
Total revenue6,7966,4326,4525,958
Gross profit5,2444,9245,0294,627
Total cost of revenue1,5521,5081,4231,331
Total operating expense4,4384,0714,0653,680
Selling / general / administrative1,6531,3811,4661,355
Research & development1,1901,1061,124946
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)40807049
Other operating expenses, total--------
Operating income2,3582,3612,3872,278
Interest income (expense), net non-operating-316-271-245-215
Gain (loss) on sale of assets--------
Other--------
Income before tax1,9982,0142,0961,776
Income after tax1,3911,5981,6101,354
Income tax, total607416486422
Net income1,3911,5981,6101,354
Total adjustments to net income--------
Net income before extra. items1,3911,5981,6101,354
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,3911,5981,6101,354
Inc. avail. to common incl. extra. items1,3911,5981,6101,354
Diluted net income1,3911,5981,6101,354
Dilution adjustment--------
Diluted weighted average shares1,6251,6401,6321,625
Diluted EPS excluding extraordinary itemsvalue per share0.860.970.990.83
Dividends per sharevalue per share0.570.570.570.57
Diluted normalized EPSvalue per share0.881.021.030.86